- Home
- DD
as 02-21-2025 4:00pm EST
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics, water, construction, safety and protection, automotive, and healthcare industries. DuPont plans to spin off its electronics business by the end of 2025.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | WILMINGTON |
| Market Cap: | 34.8B | IPO Year: | N/A |
| Target Price: | $98.00 | AVG Volume (30 days): | 2.6M |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.67 | EPS Growth: | 79.59 |
| 52 Week Low/High: | $68.21 - $90.06 | Next Earning Date: | 02-11-2025 |
| Revenue: | $12,386,000,000 | Revenue Growth: | 2.64% |
| Revenue Growth (this year): | 7.46% | Revenue Growth (next year): | 5.16% |
Latest DuPont de Nemours Inc. News
DD Breaking Stock News: Dive into DD Ticker-Specific Updates for Smart Investing
Simply Wall St.
8 hours ago
DuPont de Nemours' (NYSE:DD) Performance Is Even Better Than Its Earnings Suggest
PR Newswire
a day ago
DuPont Announces Increase in Quarterly Dividend on Common Stock
PR Newswire
a day ago
DuPont Announces Appointment of Kurt McMaken to Board of Directors
Zacks
2 days ago
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
Zacks
9 days ago
Top Research Reports for JPMorgan, Costco & SAP
MT Newswires
9 days ago
Citigroup Adjusts Price Target on DuPont de Nemours to $95 From $88, Maintains Buy Rating
MT Newswires
9 days ago
Barclays Upgrades DuPont de Nemours to Equalweight From Underweight, Adjusts Price Target to $89 From $85
MT Newswires
10 days ago
BMO Capital Adjusts Price Target on DuPont de Nemours to $112 From $105
Compare DD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DD DuPont de Nemours Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.